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Sulfur mustard (SM) is a toxic compound that can target human spermatozoa. It induces a wide variety of pathologic 
effects in human reproductive organ, including disturbance in sexual hormones, testicular atrophy, impaired 
spermatogenesis, poor quality of sperm, defetcs in embryo development, childhood physical abnormalities, and severe 
fertility problems. However, molecular and cellular mechanisms of SM action on male reproductive health and human 
sperm function are not clear. Excessive production of reactive oxygen species (ROS) and resulted oxidative stress (OS) is 
likely a significant mechanism of SM action which can be associated with sperm DNA damage, membrane lipid 
peroxidation, reduced membrane fluidity, mitochondrial deficiency, apoptosis, and poor sperm quality. In this review, we 
aim to discuss cellular and molecular mechanisms of SM action on sperm and reproductive health, the significance of OS 
and mechanisms by which SM enhances infertility rate among SM-exposed individuals.  
Key words: Sulfur mustard, human infertility, sperm, oxidative stress, reproductive system 
Introduction 
Sulfur mustard (SM), is a lipophilic compound which has 
been applied as a chemical warfare agent. During Iran-Iraq war 
(1980-1988), the unconventional use of SM injured more than 
100,000 Iranians in which one-third of them are still suffering from 
the chronic effects 
1, 2
. A great number of studies have reported 
different pathological and clinical effects of SM exposure in various 
organs 
3
. Although the eyes, skin and airway system are the primary 
targets of SM toxicity 
4-6
, immunological, hematological and 
neuropsychiatric abnormalities, gastrointestinal problems, and 
sleep disorders are the other main pathological findings 
1, 7-10
.  
The reproductive organ is another significant target for 
SM toxicity. However, there are still conflict reports regarding the 
effect of SM on human sperm and male infertility. Previous studies 
reported that the infertility rate in SM-exposed men is ranged from 
2.5% to 35% 
11-13
. Disturbance in sexual hormones, structural 
damages such as testicular atrophy, impaired spermatogenesis, and 
poor quality of sperm are the proposed reasons by which SM 
affects human reproductive health and fertility outcome 
14
. 
Nevertheless, the actual mechanism in which SM triggers these 
abnormalities is not-well considered.   
Excessive production of reactive oxidative species (ROS) 
and oxidative stress (OS) seem to be a significant mechanism of SM 
action on human reproductive function 
14
. Recent studies have 
indicated that SM accelerates OS through the massive generation of 
ROS from endogenous sources or decrease in antioxidant 
capabilities and oxidative DNA repair 
15
. The resulted OS then, in 
turn, can damage DNA leading to chromosome instability, altered 
gene expression, apoptosis and cell death 
16, 17
. SM can also form 
adducts with DNA, lipids and proteins 
18
, and suppress nucleic acid 
and protein biosynthesis, which is associated with ATP depletion 
and disruption of intracellular energy metabolisms. Therefore, SM 
toxicity can be resulted from the direct damage induced by 
alkylating cellular components or ROS overproduction and oxidative 
stress.  
Since human sperm membrane contains higher 
percentage of unsaturated fatty acid in contrast with other cells, it 
is particularly susceptible to OS and ROS. Therefore, spermatozoa 
can be considered as a major candidate for the pathologic and 
cytotoxic effects of SM 
19
. In the following sections, we will discuss 
the general reproductive effects of SM, as well as the significance 
of OS and the mechanisms by which SM induces ROS generation 
and antioxidants depletion in reproductive organs.  
 
Gonadotoxicity effect of SM 
Although several studies considered negative effects of 
SM on human reproductive health, data addressing the adverse 
effects of SM on sperm function and male infertility are increasing. 
A growing number of clinical investigations and experimental 
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studies have revealed that SM affects male reproductive system 
through the several mechanisms, including disturbance of sexual 
hormones, testicular atrophy, sexual dysfunction, genital lesions, 
impaired spermatogenesis, and poor sperm quality 
14
 (Figure 1). 
Table 1 shows a list of human and animal based studies that 
considered chronic and severe effects of SM on male reproductive 
function and sperm quality. 
 
 
 
  
 
Figure 1. SM affects male reproductive system through the 
several mechanisms, including disturbance of sexual 
hormones, testicular damages, sperm DNA damages, 
impaired spermatogenesis, and poor sperm quality.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1. Gonadotoxicity effects of SM on male reproductive 
function 
Study 
model 
Times after 
exposure 
Findings   Refs  
Human  Several 
years 
↓ferDlity rate (23.3%); ↓quality of 
sperm (38.7%);    ↑aborDon 
(13.6%); ↑sexual dysfuncDon (9%); 
↓libido (30%); ↑premature 
ejaculation (23.6%); ↑sex hormone 
deficiency, ↑FSH (57.6%); ↑LH 
(66.3%)   
24, 25
 
Human  1
st
 week  ↓free serum testosterone (FT);  
↓dehydroepiandrosterone (DHES) 
89, 90
 
Human  5
th
 week  ↓FT; ↓DHES 20 
Human  3
rd
 and 5
th
 
week  
↑serum FSH; ↑serum LH     
20
 
Human  3 years  ↓FT; ↑tesDcular atrophy;  
↑impaired spermatogenesis;  
↑Sertoli cells only paGern 
20, 
23, 91
 
Human  20 years  Normal LH, FSH and Testosterone  21 
Human  3 months  ↑Oligozoospermia (33.3%) 20 
Human  4 years  ↑total sperm counts 21 
Human  10 years  ↑abnormal sperm (38%);  
↑sperm with abnormal morphology 
(54%);  
↓sperm moDlity (48%)  
13
 
Human  15 years  ↑Oligozoospermia (10%) 11 
Human  20 years  ↓semen volume; ↓sperm counts;  
↓sperm moDlity; ↓ sperm with 
normal morphology 
21-23
 
Human  20 years  ↑sperm with DNA damages 81 
Human  8 years  ↓libido (33.3%) 
↑erecDle dysfuncDon (9%);  
↑premature ejaculaDon (23.6%) 
25
 
Human  Few hours or 
few days  
↑genital lesions; 
↑hypopigmentaDon  
2, 39
 
Male rats  10 days  ↑abnormal sperm; ↓sperm counts;  
↓sperm moDlity 
29
 
Male rats 10 days  ↑abnormal sperm; ↓Sperm 
counts;  
↓sperm moDlity;  
↓FT; ↓tesDcular weight  
92
 
 
 
Structural changes and impaired spermatogenesis   
Several lines of studies have shown that SM has a 
significant effect on testes structure and function. Testicular biopsy 
of SM-exposed patients revealed complete or relative arrest of 
spermatogenesis, atrophy of the germinal epithelium, but normal 
Sertoli and Leydig cells 
20-23
. These data suggest that 
spermatogenesis is a significant target of SM toxicity. 
Spermatogenesis deficiency in SM-exposed individuals can provide 
further pathologic effects such as low semen volume because of 
ejaculatory duct obstruction, as well as poor sperm quality. Sexual 
dysfunction is reported among SM victims. In a study by Pour-Jafari 
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et al., 
24
 among 800 SM-exposed Iranian men, 35% had decreased 
libido 
24
. A previous study reported erectile dysfunction (9%) and 
premature ejaculation (23.3%) in SM-exposed patients 
25
. These 
complications may be because of decreased level of serum 
testosterone. Other studies reported genital lesions such as 
hyperpigmentation, xerosis, and scars at the sites SM-induced 
injuries 
26-28
.  
Effects of SM exposure on testes structure and 
spermatogenesis have been also studied in animal models. For 
instance, increased percentage of abnormal spermatozoa and 
impaired spermatogenesis were observed in male rats exposed to 
0.50 mg/kg
-1
 SM 
29
. Change in testicular integrity and decrease in 
testicular weight were detected in male rates after intraperitoneal 
injection of SM 
30, 31
. Other studies reported that intravenous 
injection of SM in male mice caused testes damage and 
spermatogenesis deficiency 
30, 32
. Furthermore, increased distance 
between seminiferous tubules, presence of necrotic forms of 
spermatocytes, and necrotic cells in the lumen were found eight 
weeks after SM-exposed rats 
32
. Therefore, degenerative changes in 
testicular structure can be considered as one of the main 
mechanisms of SM that may be associated with impaired 
spermatogenesis, decrease in the number of spermatozoa, poor 
sperm quality and eventually male infertility.  
 
Sperm quality  
Several lines of studies indicated that SM exposure results 
in poor sperm quality, which suggests spermatozoa are particularly 
susceptible to cytotoxic effects of SM. For example, a previous 
study found azoospermia and severe oligospermia in 42.5% and 
57.5% of SM- exposed patients, respectively 
23
. Shakeri et al., 
33
 
considered abnormal sperm morphology (53.8%), reduced sperm 
motility (48.4%), low sperm count (23.1%), as well as abnormal 
semen viscosity (17.6%) and declined semen volume (16.5%) in SM-
exposed patients. In another study, semen analysis was performed 
for patients who exposed to SM during the Iran-Iraq war. The 
results showed sperm abnormalities in 38% of the SM victims 
13
. In 
another research, the long-term effects of SM on the testis and 
male fertility were considered two decades after exposure. Male 
factor infertility was detected in 23% of SM-exposed patients and 
all semen indices were significantly decreased 
21
. Therefore, these 
data suggest that spermatozoa can be a possible target for SM 
effects in the testis.  
 
Deficiency of sexual hormone  
SM exposure may disturb reproductive hormones, which 
are critical for regulation and initiation of spermatogenesis 
34
. 
Furthermore, SM can interfere with the hypothalamus-hypophysis-
testis axis, which is associated with impaired spermatogenesis and 
poor quality of sperm (Figure 2).  
Gonadotropins, including follicle-stimulating hormone 
(FSH) and Luteinizing hormone (LH), and testosterone, are key 
regulators of germ cell development and spermatogenesis. Altered 
expression and secretion of gonadotropins and testosterone can be 
associated with abnormal spermatogenesis and male infertility. 
Previous studies showed significant changes in plasma levels of 
gonadotropins and testosterone in SM-exposed patients 
20, 21, 23, 32, 
35
. For instance, increased level of FSH was observed in serum of 
patients who exposed to SM 
20, 21
. In a long-term study, Azizi et al., 
20
 found that exposure to SM reduces androgen level and hypo-
responsiveness to GnRH. They also found that serum total and free 
testosterone and dehydroepiandrosterone were markedly 
decreased after SM exposure 
20
. In another study, Agin and 
Sarvghadi 
36
 found reduced serum free testosterone levels in 32.6% 
of SM-exposed patients.  
Since sperm counts are positively correlated with 
testosterone level, a marked reduction of intratesticular 
testosterone contents can initiate germ cell apoptosis in the 
seminiferous epithelium 
37
. Therefore, any reduction of 
testosterone concentration caused by SM may interfere with the 
initiation of spermatogenesis, and lead to germ cell apoptosis and 
low quality of sperm. Additionally, there is a significant relationship 
between high serum FSH level with reduced number of sperm and 
abnormal morphology of spermatozoa 
20
. Increased FSH level is an 
indicative of abnormal spermatogenesis and may suggest primary 
testicular failure. These findings indicate that a reduced sperm 
count in SM exposed patients is attributable to a primary testicular 
injury and a proof supporting the idea of SM gonadotoxicity 
21
. 
However, it seems that serum levels of the reproductive hormones 
are within the normal range in SM-exposed men several years after 
the injury, which is dose depended 
14
. 
 
 
 
 
 
Figure 2. The pathologic effects of SM on hypothalamus-
hypophysis-testis axis which disrupt the reproductive hormones 
and spermatogenesis process   
 
 
 
Mechanisms of SM action  
Since SM is a lipophilic compound, it can be easily 
absorbed and quickly entered into the body through the eyes, skin 
and respiratory system 
26
. Afterward, it distributes systemically 
through the circulatory system and affects various organs, 
especially reproductive system. Recent evidences have suggested 
that SM toxicity is mediated through the several mechanisms such 
as damages to macromolecules, depletion of cellular nicotinamide 
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adenine dinucleotide (NAD), increase of cellular calcium levels, 
increase of apoptosis mediators, oxidative stress, inflammation, and 
cellular antioxidant depletion 
38
 (Figure 3).  
 
 
 
 
 
Figure 3. Possible cellular and molecular mechanisms of SM action on 
apoptosis and cells death  
 
 
Damages to macromolecules 
When SM absorbed, it undergoes intramolecular 
cyclization and forms a sulphonium ion, which in turn alkylates 
DNA, lipids and proteins, leading to DNA strand breaks and 
consequently cell death 
39, 40
. These cellular effects are associated 
with tissue responses such as synthesis and secretion of 
inflammatory mediators and tissue damage (Figure 3) 
41
.   
DNA damage is the primary initiator of the cellular 
responses which is associated with clinical injuries 
8
. SM induces 
different structural modifications in DNA, which can lead to DNA 
strands breaks, genotoxic stresses, proteins or genome 
modifications, deficiency of DNA replication and transcription, cell 
cycle arrest, apoptosis and cell death 
18
. SM can also directly 
interact with proteins and interfere with their normal function 
through the miss folding, oxidation, cross-linking and enzyme 
disability 
38
. Lipids are the other targets for SM that can be 
peroxidized when exposed to SM, and then free radicals will be 
released as byproducts of lipid peroxidation 
14
.  
 
Depletion of nicotinamide adenine dinucleotide  
NAD depletion is another mechanism of SM action. Upon 
SM-induced DNA damage, DNA repair systems such as Poly (ADP-
ribose) polymerase (PARP) pathway, base excision repair, and 
nucleotide excision repair are activated 
38
. Recent evidences have 
revealed that DNA breaks induce PARP activation that lead to NAD
+ 
or ATP depletion and stimulation of the NADP
+ 
dependent 
hexosemonophosphate shunt; this event in turn enhances synthesis 
and release of proteases 
42
. Increased expression and activation of 
proteases is associated with cell death and tissue injuries 
43
 (Figure 
3). Previous studies demonstrated that the PARP produces poly-
(ADP-ribose) (PAR) alone that induces signals for apoptosis and cell 
death 
44
.  
 
Calcium (Ca
2+
) releasing   
Recent evidences have considered calmodulin and 
increases in intracellular Ca
2+
 levels as a signaling molecule induced 
by SM exposure 
45
. Calmodulin and increased content of 
intracellular Ca
2+ 
play an important role in apoptosis and cell death 
(Figure 3). Cytosolic calcium can be increased by the activity of 
protein kinase (PK) signaling pathways that lead to the activation of 
phospholipase C (PLC) and the generation of inositol triphosphate 
(IP3), which acts on calcium channels to release it from intracellular 
stores 
46
. Another possible mechanism of cytosolic Ca
2+ 
enhancement is due to the massive production of reactive oxygen 
species (ROS) caused by SM. ROS react with Ca
2+
 transport channels 
inside the endoplasmic reticulum, mitochondria, and cell 
membrane. These interactions damage the Ca
2+
 transport channels, 
which result in an influx of Ca
2+
 into the cytosol 
47
. Increased 
contents of cytosolic Ca
2+
 not only induce activity of proteases such 
as Caspases, but also it induces Phospholipases and Endonucleases 
activity which in turn degrade cellular proteins, lipids and DNA 
48
 
(Figure 3).   
 
Mediators of apoptosis  
Previous studies demonstrated that SM induces the 
overexpression of FasL and Fas, as an apoptotic signaling, in 
damaged cells 
49
. FasL and Fas induce Caspases activation, which in 
turn lead to protein degradations and apoptosis (Figure 3). The 
other signaling molecules such as NF-κB, p38, and p53 are mediator 
factors that trigger numerous cellular responses such as 
inflammation, apoptosis, proliferation, and differentiation 
50, 51
. SM 
induces these mediators and leads to inflammation, apoptosis or 
cell death in SM-damaged cells.  
 
Oxidative stress and infertility of men 
Massive generation of ROS and OS is likely a main reason 
for poor sperm quality and male infertility in SM exposed patients. 
Oxidative stress is defined as the imbalance between the ROS 
generation and the cellular antioxidant systems 
52
. ROS are highly 
reactive free radicals which are produced by living organisms during 
normal cellular metabolism 
52, 53
. At high concentrations, they can 
interact with lipids, proteins, and DNA and adversely affect certain 
cellular processes and modify normal cells function 
54
. However, 
ROS are critical for normal sperm function such as acrosome 
reaction and sperm capacitation at low concentrations 
55
.  
OS has been suggested as one of the main reasons for low 
quality of sperm and male infertility 
55-57
. Recent studies have 
indicated that immature spermatozoa or abnormal sperm cells and 
leukocytes are the major sources of ROS in human semen 
58
. ROS 
target sperm membrane lipids, DNA and proteins; alter enzymatic 
systems; produce irreversible alterations; cause cell death; and 
ultimately, lead to a decline in the semen parameters associated 
with male infertility 
58
 (Figure 4).  
ROS can decrease the fluidity of sperm plasma 
membrane, leading to loss of the sperm ability for oocyte fusion 
and fertilization 
59
. Since human spermatozoa contain high 
percentage of polyunsaturated fatty acids (PUFA) in their plasma 
membrane, they are very susceptible to ROS 
60
. PUFA are critical for 
the fluidity of sperm membrane, ion transport, and sperm 
capacitation within the female reproductive tract. Therefore, sperm 
lipid peroxidation negatively affects membrane function, its 
transport activity and eventually surviving of spermatozoa (Figure 
4). Lipid peroxidation has also a deleterious effect on the 
ultramorphological structure of sperm cells and thereby on the 
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male fertilization potential 
61
. Oxidation of sperm membrane lipids 
axonemal proteins can be associated with permanent impairment 
of sperm motility because excessive ROS deplete cellular ATP 
resulting in decreased phosphorylation of axonemal proteins and 
cause transient impairment of motility, as well as decreased sperm 
viability 
58
.  
 
 
 
 
Figure 4. Mechanisms through which SM induces oxidative stress and 
male infertility 
 
 
Numerous studies have also revealed that ROS can target 
sperm DNA by causing base modification, DNA strand breaks, DNA 
fragmentation and deletions, mutations, and chromatin cross-
linking 
61-65
. DNA damages can increase germ cells apoptosis and 
reduce sperm counts 
66
 (Figure 4).   
In order to counteract the toxic effects of ROS, human 
seminal plasma and spermatozoa are equipped with enzymatic and 
non-enzymatic antioxidants that act as ROS scavenger, thereby 
protecting sperm cells from oxidative damage 
58
. The seminal 
plasma antioxidants are very important because they compensate 
the depletion of sperm cytoplasmic enzymes when the cytoplasm is 
extruded during maturation 
67
. Nevertheless, overproduction of 
ROS in reproductive organ can overwhelm the effective contents of 
antioxidants, increasing the harmful effects of ROS to spermatozoa 
that are associated with abnormal sperm parameters 
68
. SM can 
lead to excessive production of ROS causing progressive oxidative 
damage and ultimately sperm cells death.    
 
Role of SM in oxidative stress and inflammation  
OS induced by free radicals is now believed as one of the 
main mechanisms of SM toxicity 
69, 70
. SM increases ROS production 
and OS via several mechanisms, including accumulation of 
leukocytes and inflammation, reduced activity of antioxidants, 
enhanced expression of ROS producing-related enzymes, 
mitochondrial dysfunction, depletion of glutathione (GSH) and 
productivity of GSH-dependent antioxidant enzymes, as well as 
change in activity of inducible nitric oxide synthase (iNOS) 
71
 (Figure 
4).  
A growing number of studies have confirmed a close 
relationship between the presence of leukocytes in semen and male 
infertility 
63
. Some studies have revealed that elevated levels of 
seminal ROS, IL-6, IL-8, and tumor necrosis factor-α (TNF-α) are 
associated with increased content of sperm membrane lipid 
peroxidation and poor sperm quality 
72-74
. Recent evidences have 
revealed that SM exposure is significantly associated with 
inflammatory reactions and oxidative injury at the site of damaged 
tissues 
70, 75, 76
. Experimental studies showed that SM can induce the 
secretion of several proinflammatory cytokines and growth factors 
such as TNFα, IL-α, IL-β, IL-6, IL-8, IL-13, IL-15, and INF-γ in damaged 
tissues 
77-80
. SM can also accumulate several inflammatory cells 
such as macrophages and neutrophils with a subsequent release of 
inflammatory mediators that can recruit and activate other 
leukocytes in reproductive system 
14
. Activated leukocytes generate 
high levels of ROS which in turn overwhelm the antioxidant defense 
systems, leading to increased OS in seminal plasma. Overproduction 
of ROS by SM-activated leukocytes cause oxidative damage to 
sperm DNA, protein and membrane PUFA, which are associated 
with further inflammations, impaired spermatogenesis, apoptosis 
and poor quality of sperm 
81
 (Figure 4).  
Several studies have shown that SM induces 
mitochondrial dysfunction, which may be associated with electron 
transport chain deficiency, massive production of ROS, DNA 
oxidation and depletion of intracellular antioxidants 
69, 82
. 
Spermatozoa are rich in mitochondria because a constant supply of 
ATP is necessary for their motility. Increased number of abnormal 
or immature spermatozoa significantly enhances ROS generation, 
which in turn affects their mitochondrial function and subsequently, 
sperm motility 
58, 83
.  
SM can also impair spermatogenesis and induce sperm 
DNA fragmentation. In a previous study, the relationship between 
SM exposure and sperm DNA fragmentation was considered two 
decades after SM exposure 
81
. A significant increase in sperm DNA 
fragmentation index was found in SM patients, indicating the 
increased risk of congenital abnormalities and genetic defects in 
SM-exposed victims offspring created by assisted reproductive 
techniques (ART) technique 
22, 81
.    
SM can also decline the effective concentration of 
antioxidants through the enhancing of ROS generation (Figure 4). 
Glutathione (GSH) is a primary target for SM because its level has 
been markedly reduced after SM exposure 
80
. SM-GSH metabolites 
decrease cellular GSH and increase intracellular ROS, as well as OS 
markers including DNA, lipid and protein oxidations 
80
. Recent 
investigators have demonstrated that GSH and N-acethylcysteine 
(as a GSH prodrug) treatments, reduce OS and toxicity induced by 
SM 
84-86
. SM can also decrease the activity of other antioxidants 
such as thioredoxin reductase, catalases (CAT), superoxide 
dismutase (SOD), glutathione reductase (GR), glutathione 
peroxidase (GPX) and glutathione-S-transferases (GST), which are 
critical in the control of cellular antioxidants balance 
79, 87
. Reduced 
activity of these antioxidants can occur as a result of SM-induced 
alkylation or changes in expression of theses enzymes.  
NADPH cytochrome p450 reductase, which has a critical 
role detoxification of different toxic metabolites, is another target 
for SM 
88
. Several research have shown that SM not only inhibits the 
reduction of cytochrome C, but also it prevents the activity of 
NADPH cytochrome p450 reductase and stimulates ROS generation 
88
.  
Conclusions 
SM induces a wide variety of structural and functional 
disorders in reproductive system, including deficiency of 
Page 5 of 7 Toxicol gy Re earch
To
xi
co
lo
gy
R
es
ea
rc
h
A
cc
ep
te
d
M
an
us
cr
ip
t
Pu
bl
ish
ed
 o
n 
09
 Ju
ly
 2
01
8.
 D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
ity
 o
f C
al
ifo
rn
ia
 - 
Sa
nt
a B
ar
ba
ra
 o
n 
7/
14
/2
01
8 
10
:1
1:
56
 A
M
. 
View Article Online
DOI: 10.1039/C8TX00062J
ARTICLE Journal Name 
6 | J. Name., 2012, 00, 1-3 This journal is © The Royal Society of Chemistry 20xx 
Please do not adjust margins 
Please do not adjust margins 
reproductive hormones, testicular cells damages, sexual 
dysfunction, spermatogenesis deficiency, poor sperm quality, and 
reduced fertility. OS is a major mechanism of SM action on human 
reproductive health. SM induces DNA fragmentation, lipid and 
protein oxidation and as the result sperm apoptosis. It induces OS in 
reproductive system via several mechanisms, including 
accumulation of leukocytes and inflammatory mediators, 
mitochondrial deficiency, enhanced activity of ROS-producing 
enzymes, reduced activity of intracellular antioxidants, GSH 
depletion and decreased productivity of GSH-dependent 
antioxidants, and consequently imbalances between the production 
and detoxification of ROS in cells. Therefore, antioxidant therapy 
may be helpful to protect reproductive function against SM-induced 
damages.  
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